Insights

Strategic Growth Strong global footprint with FibroScan® in over 140 countries and a growing leadership with a new CEO in 2026, presenting expansion opportunities in underserved markets and channel partnerships with regional distributors and healthcare providers.

Noninvasive Leadership Established market leader in liver diagnostics with widespread clinical adoption, peer-reviewed support, and international guideline prominence, offering upsell potential for bundled liver health management solutions and companion services.

Partnership Potential Recent collaborations with gastroenterology networks and research communities create openings for co-marketing, joint clinical studies, and deployment of FibroScan across additional clinics and hospital systems.

Digital Outreach Active patient education and digital engagement through myliverexam and a tech stack that supports marketing automation, analytics, and regional campaigns, enabling targeted demand generation and physician outreach.

Financial Footing Mid-sized revenue profile with solid funding and profitability potential, suggesting suitability for scalable regional deployments, refurbished equipment programs, and service contracts to drive recurring revenue.

Similar companies to Echosens

Echosens Tech Stack

Echosens uses 8 technology products and services including Linkedin Insight Tag, Microsoft Clarity, Amazon Web Services, and more. Explore Echosens's tech stack below.

Media & News

Echosens's Email Address Formats

Echosens uses at least 4 email formats:
Echosens Email FormatsExamplePercentage
First.Last@echosens.comJohn.Doe@echosens.com
97%
Last@echosens.comDoe@echosens.com
1%
First.MiddleLast@echosens.comJohn.MichaelDoe@echosens.com
1%
First@echosens.comJohn@echosens.com
1%

Frequently Asked Questions

What is Echosens's phone number?

Minus sign iconPlus sign icon
You can contact Echosens's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Echosens's official website and social media links?

Minus sign iconPlus sign icon
Echosens's official website is echosens.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Echosens generate?

Minus sign iconPlus sign icon
As of August 2026, Echosens's annual revenue is estimated to be $50M - $100M.

What is Echosens's NAICS code?

Minus sign iconPlus sign icon
Echosens's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Echosens have currently?

Minus sign iconPlus sign icon
As of August 2026, Echosens has approximately 389 employees across 5 continents, including Europe, North America and Asia. Key team members include Chief Marketing Officer: J. M., Chief Commercial Officer - International Markets: C. M. and Chief People Officer: C. G. Explore Echosens's employee directory with LeadIQ.

What industry does Echosens belong to?

Minus sign iconPlus sign icon
Echosens operates in the Medical Equipment Manufacturing industry.

What technology does Echosens use?

Minus sign iconPlus sign icon
Echosens's tech stack includes Linkedin Insight Tag, Microsoft Clarity, Amazon Web Services, HashiCorp Terraform, Jenkins, Cookiebot, Pardot and Microsoft Teams.

What is Echosens's email format?

Minus sign iconPlus sign icon
Echosens's email format typically follows the pattern of First.Last@echosens.com. Find more Echosens email formats with LeadIQ.

How much funding has Echosens raised to date?

Minus sign iconPlus sign icon
As of August 2026, Echosens has raised $33M in funding. The last funding round occurred on Mar 09, 2018.

When was Echosens founded?

Minus sign iconPlus sign icon
Echosens was founded in 2001.
Echosens logo

Echosens

Medical Equipment ManufacturingÎle-de-France, France201-500 Employees

Echosens is a medical equipment manufacturer based in Paris, France, headquartered at 6 Rue Ferrus, Île-de-France 75014, and employing 201–500 people. The company developed FibroScan®, a non-invasive device used to assess liver fibrosis and steatosis, and positions it as a reference standard with adoption in more than 100 countries and millions of liver examinations; the program is supported by more than 4,200 peer‑reviewed publications and over 180 international guidelines. FibroScan was introduced in 2003 as the first commercially available transient elastography device for liver assessment. Echosens collaborates with physicians, medical research communities, and pharmaceutical companies for patient identification and monitoring in NAFLD/NASH, and maintains patient education materials through the myliverexam website. Recent developments include launching the LHM platform globally in 2024, appointing a new Group Chief Executive Officer effective May 1, 2026, and a 2025 partnership with United Digestive; the company has also been recognized as a top place to work in 2024 and 2025.

Section iconCompany Overview

Phone number
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2001
Employees
201-500

Section iconFunding & Financials

  • $33M

    Echosens has raised a total of $33M of funding over 3 rounds. Their latest funding round was raised on Mar 09, 2018 as a Private Equity.

  • $50M - $100M

    Echosens's revenue is estimated to be in the range of $50M - $100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.